Medicine & Life Sciences
2-(4-bromo-2,5-dimethoxyphenyl)-N-((2-methoxyphenyl)methyl)ethanamine
29%
2-(4-bromo-2,5-dimethoxyphenyl)ethylamine
18%
3-(4-(4-(3-methoxyphenyl)piperazine-1-yl)butyl)-1,3-dihydro-2H-indol-2-one
16%
4-iodoamphetamine
17%
6-hydroxyquinoline
15%
Brain
30%
Carbon-11
22%
Cimbi-36
100%
Demethylation
15%
Diclofenac
15%
dimethyl-(2-(3-(1,3,5-trimethyl-1H-pyrazol-4-yl)phenyl)ethyl)amine dihydrochloride
15%
Erythrina
17%
Esters
37%
Hallucinogens
42%
Histone Demethylases
57%
In Vitro Techniques
16%
Ligands
68%
Lu AE43936
16%
N-(2-hydroxybenzyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethan-1-aminium
15%
N-benzyl-phenethylamine
42%
Neuroimaging
32%
Nicotine
16%
Nicotinic Receptors
28%
Oxindoles
24%
Pharmacology
44%
Phenethylamines
30%
Positron-Emission Tomography
66%
Prodrugs
21%
Receptor, Serotonin, 5-HT2A
99%
Receptor, Serotonin, 5-HT2C
24%
serotonin 5 receptor
21%
Serotonin 5-HT2 Receptor Agonists
71%
serotonin 7 receptor
55%
Serotonin Receptors
20%
Structure-Activity Relationship
25%
Swine
28%
Chemical Compounds
Acetylcholine
28%
Acid
20%
Agent Interacting With Transmitter, Hormone or Drug Receptor
52%
Agonist
51%
Alkaloid
17%
Antagonist
39%
Benzamides
17%
Borylation
17%
Codeine
17%
Diclofenac
16%
Dopamine
18%
Ester
36%
Histone
43%
Iodonium
17%
Ligand
39%
Lysine
22%
Metabolite
15%
Methyl Carbamate
20%
Nicotine
16%
Oxindoles
16%
Partial Agonist
16%
Pharmacological Metabolism
24%
Positron
57%
Psychodysleptic
30%
Psychodysleptic Agent
16%
Radioligand
45%
Reaction Yield
27%
Serotonin
22%
Serotonin 2A Agonist
29%
Tetrazine
18%
